Stock Comparison

RVMD vs VRTX

Revolution Medicines Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

RVMD

Revolution Medicines Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$38.71B

$124.70B

P/E (TTM)

—

29.2

Forward P/E

—

25.8

Price/Sales

9,035.1

10.2

Price/Book

25.8

6.4

EV/EBITDA

-9.7

24.0

Dividend Yield

—

Profitability

Net Margin

0.00%

35.50%

Operating Margin

0.00%

38.10%

Return on Equity

-76.70%

24.20%

Return on Assets

-37.50%

12.10%

Growth (YoY)

Revenue Growth

-95.20%

7.80%

Earnings Growth

0.00%

61.40%

Price & Risk

Beta

1.4

0.3

52-Week High

$184.39

$507.92

52-Week Low

$34.00

$362.50

Analyst Target

$188.57

$548.69

Compare RVMD and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.